TIPRL Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | O75663 |
---|---|
Clone Names | 90723261 |
Gene ID | 261726 |
---|---|
Other Names | TIP41-like protein, Putative MAPK-activating protein PM10, Type 2A-interacting protein, TIP, TIPRL |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | TIPRL |
---|---|
Function | May be a allosteric regulator of serine/threonine-protein phosphatase 2A (PP2A). Isoform 1 inhibits catalytic activity of the PP2A(D) core complex in vitro. The PP2A(C):TIPRL complex does not show phosphatase activity. Acts as a negative regulator of serine/threonine- protein phosphatase 4 probably by inhibiting the formation of the active PPP4C:PPP4R2 complex; the function is proposed to implicate it in DNA damage response by promoting H2AX phosphorylated on Ser-140 (gamma-H2AX). May play a role in the regulation of ATM/ATR signaling pathway controlling DNA replication and repair. |
Cellular Location | Cytoplasm. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
TIPRL is an inhibitory regulator of protein phosphatase-2A(PP2A) (see PPP2CA; MIM 176915), PP4 (see PPP4C; MIM 602035), andPP6 (see PPP6C; MIM 612725) (McConnell et al., 2007 [PubMed17384681]).
References
Ehret, G.B., et al. Eur. J. Hum. Genet. 17(12):1650-1657(2009)Cheung, C.L., et al. Hum. Mol. Genet. 18(4):679-687(2009)Rikova, K., et al. Cell 131(6):1190-1203(2007)McConnell, J.L., et al. Oncogene 26(41):6021-6030(2007)Ewing, R.M., et al. Mol. Syst. Biol. 3, 89 (2007) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.